相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of Oligodendrocyte Functions: Targeting Lipid Metabolism and Extracellular Matrix for Myelin Repair
Davide Marangon et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Biomarkers, Master Regulators and Genomic Fabric Remodeling in a Case of Papillary Thyroid Carcinoma
Dumitru A. Iacobas
GENES (2020)
Retinoic Acid Is Required for Oligodendrocyte Precursor Cell Production and Differentiation in the Postnatal Mouse Corpus Callosum
Vivianne E. Morrison et al.
ENEURO (2020)
The Gene Master Regulators (GMR) Approach Provides Legitimate Targets for Personalized, Time-Sensitive Cancer Gene Therapy
Sanda Iacobas et al.
GENES (2019)
Pioglitazone Confers Neuroprotection Against Ischemia-Induced Pyroptosis due to its Inhibitory Effects on HMGB-1/RAGE and Rac1/ROS Pathway by Activating PPAR-γ
Pingping Xia et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis
Alazne Zabala et al.
EMBO MOLECULAR MEDICINE (2018)
Purinergic signaling in oligodendrocyte development and function
Taylor G. Welsh et al.
JOURNAL OF NEUROCHEMISTRY (2018)
Glycogen synthase kinase-3β inhibition enhances myelination in preterm newborns with intraventricular hemorrhage, but not recombinant Wnt3A
Preeti Dohare et al.
NEUROBIOLOGY OF DISEASE (2018)
Opportunities in posthemorrhagic hydrocephalus research: outcomes of the Hydrocephalus Association Posthemorrhagic Hydrocephalus Workshop
Jenna E. Koschnitzky et al.
FLUIDS AND BARRIERS OF THE CNS (2018)
Functional Significance of the Adcy10-Dependent Intracellular cAMP Compartments
Sofya Pozdniakova et al.
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2018)
Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation
Sonia Villapol
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus
Jason K. Karimy et al.
NATURE MEDICINE (2017)
An Essential Role for TAGLN2 in Phagocytosis of Lipopolysaccharide-activated Macrophages
Hye-Ran Kim et al.
SCIENTIFIC REPORTS (2017)
Astrocyte-Specific Deletion of Peroxisome-Proliferator Activated Receptor-γ Impairs Glucose Metabolism and Estrous Cycling in Female Mice
Marina O. Fernandez et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2017)
MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development
Joshua Bloom et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Microglia development follows a stepwise program to regulate brain homeostasis
Orit Matcovitch-Natan et al.
SCIENCE (2016)
The P2X4 receptor is required for neuroprotection via ischemic preconditioning
Tomohiko Ozaki et al.
SCIENTIFIC REPORTS (2016)
Localization of PPAR isotypes in the adult mouse and human brain
Anna Warden et al.
SCIENTIFIC REPORTS (2016)
Rosiglitazone Promotes White Matter Integrity and Long-Term Functional Recovery After Focal Cerebral Ischemia
Lijuan Han et al.
STROKE (2015)
CCL2-CCR2 Signaling in Disease Pathogenesis
Tracy O'Connor et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2015)
Relationship between interleukin-1 type 1 and 2 receptor gene polymorphisms and the expression level of membrane-bound receptors
F. F. Vasilyev et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Intraventricular Hemorrhage and Neurodevelopmental Outcomes in Extreme Preterm Infants
Srinivas Bolisetty et al.
PEDIATRICS (2014)
IRF7: activation, regulation, modification and function
S. Ning et al.
GENES AND IMMUNITY (2011)
Bone Morphogenetic Protein Inhibition Promotes Neurological Recovery after Intraventricular Hemorrhage
Krishna Dummula et al.
JOURNAL OF NEUROSCIENCE (2011)
Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition
Govindaiah Vinukonda et al.
BRAIN (2010)
The nuclear receptor PPARγ as a therapeutic target for cerebrovascular and brain dysfunction in Alzheimer's disease
Nektaria Nicolakakis et al.
FRONTIERS IN AGING NEUROSCIENCE (2010)
Peroxisome Proliferator-Activated Receptor-γ Agonists Promote Differentiation and Antioxidant Defenses of Oligodendrocyte Progenitor Cells
Antonietta Bernardo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Intraventricular Hemorrhage in Premature Infants: Mechanism of Disease
Praveen Ballabh
PEDIATRIC RESEARCH (2009)
Consequences of Intraventricular Hemorrhage in a Rabbit Pup Model
Caroline O. Chua et al.
STROKE (2009)
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
Ramya Kapadia et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
PPAR-gamma: Therapeutic Potential for Multiple Sclerosis
Paul D. Drew et al.
PPAR RESEARCH (2008)
Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists
Antonietta Bernardo et al.
PPAR RESEARCH (2008)
Angiogenic inhibition reduces germinal matrix hemorrhage
Praveen Ballabh et al.
NATURE MEDICINE (2007)
Hematoma resolution as a target for intracerebral hemorrhage treatment:: Role for peroxisome proliferator-activated receptor γ in microglia/macrophages
Xiurong Zhao et al.
ANNALS OF NEUROLOGY (2007)
Thiazolidinedione class of peroxisome proliferator-activated receptor γ agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats
Seung-Won Park et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
15d-prostaglandin J2 activates peroxisome proliferator-activated receptor-γ, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats
Xiurong Zhao et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)
The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice
B Schütz et al.
JOURNAL OF NEUROSCIENCE (2005)
Receptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key?
DL Feinstein et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: Implications for multiple sclerosis
PD Storer et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
A peroxisome proliferator-activated receptor-γ agonist reduces infarct size in transient but not in permanent ischemia
T Shimazu et al.
STROKE (2005)
Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease
T Breidert et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Trends in mortality and morbidity for very low birth weight infants, 1991-1999
JD Horbar et al.
PEDIATRICS (2002)
Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis
A Diab et al.
JOURNAL OF IMMUNOLOGY (2002)
Effect of cyclic AMP on the expression of myelin basic protein species and myelin proteolipid protein in committed oligodendrocytes: Differential involvement of the transcription factor CREB
FS Afshari et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
分享论文
